Structure-activity studies of endothelin leading to novel peptide ETA antagonists

Bioorg Med Chem. 1993 Jul;1(1):59-65. doi: 10.1016/s0968-0896(00)82103-3.

Abstract

With the goal of producing receptor antagonists, numerous monocyclic and bicyclic endothelin analogs were prepared and tested for vasoconstrictor activity, receptor affinity and functional antagonist activity. Bis-penicillamine endothelin analogs containing Ala or Asn at position 18 were functional antagonists, with Ki values of 20-40 nM but KB values of about 1 microM (e.g., [Pen1,11, Nle7, Ala18]-endothelin-1, Ki = 42 nM, KB = 1.2 microM). While these peptides are antagonists at the ETA receptor, they appear to be at least partial agonists at another receptor subtype.

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Carotid Arteries
  • Endothelin Receptor Antagonists*
  • Endothelin-1 / analogs & derivatives
  • Endothelins / chemistry
  • Endothelins / pharmacology*
  • Guinea Pigs
  • Molecular Sequence Data
  • Muscle, Smooth, Vascular / drug effects
  • Rabbits
  • Radioligand Assay
  • Rats
  • Receptor, Endothelin A
  • Receptors, Endothelin / metabolism
  • Structure-Activity Relationship
  • Vasoconstriction / drug effects

Substances

  • Endothelin Receptor Antagonists
  • Endothelin-1
  • Endothelins
  • Receptor, Endothelin A
  • Receptors, Endothelin
  • endothelin-1, Pen(1,11)-Nle(7)-Ala(18)-
  • endothelin-1, Pen(1,11)-Nle(7)-Asn(18)-